TELMISARTAN HCTZ-DRLA 40/12.5 telmisartan and hydrochlorothiazide 40/12.5 mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

hydrochlorothiazide, Quantity: 12.5 mg; telmisartan, Quantity: 40 mg

Available from:

Dr Reddys Laboratories Australia Pty Ltd

INN (International Name):

Hydrochlorothiazide,Telmisartan

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: iron oxide red; magnesium stearate; sodium hydroxide; lactose monohydrate; meglumine; polysorbate 80; mannitol; povidone

Administration route:

Oral

Units in package:

56 Tablets, 28 Tablets, 98 Tablets, 7 Tablets, 14 Tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.

Product summary:

Visual Identification: Oblong, uncoated bilayered tablet, light pink to pink on one side and white to off-white on other side,'T'&'1' debossed on either side of break line.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2013-11-28